1. Home
  2. PTGX vs HTH Comparison

PTGX vs HTH Comparison

Compare PTGX & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • HTH
  • Stock Information
  • Founded
  • PTGX 2006
  • HTH 1998
  • Country
  • PTGX United States
  • HTH United States
  • Employees
  • PTGX N/A
  • HTH N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • HTH Major Banks
  • Sector
  • PTGX Health Care
  • HTH Finance
  • Exchange
  • PTGX Nasdaq
  • HTH Nasdaq
  • Market Cap
  • PTGX 3.3B
  • HTH 1.9B
  • IPO Year
  • PTGX 2016
  • HTH 2004
  • Fundamental
  • Price
  • PTGX $50.65
  • HTH $31.28
  • Analyst Decision
  • PTGX Strong Buy
  • HTH Hold
  • Analyst Count
  • PTGX 9
  • HTH 2
  • Target Price
  • PTGX $67.11
  • HTH $33.00
  • AVG Volume (30 Days)
  • PTGX 969.4K
  • HTH 413.2K
  • Earning Date
  • PTGX 08-05-2025
  • HTH 07-24-2025
  • Dividend Yield
  • PTGX N/A
  • HTH 2.30%
  • EPS Growth
  • PTGX N/A
  • HTH 15.07
  • EPS
  • PTGX 0.86
  • HTH 1.97
  • Revenue
  • PTGX $207,801,000.00
  • HTH $1,208,822,000.00
  • Revenue This Year
  • PTGX N/A
  • HTH N/A
  • Revenue Next Year
  • PTGX $47.15
  • HTH $1.36
  • P/E Ratio
  • PTGX $57.63
  • HTH $15.89
  • Revenue Growth
  • PTGX N/A
  • HTH 2.13
  • 52 Week Low
  • PTGX $32.50
  • HTH $26.67
  • 52 Week High
  • PTGX $60.60
  • HTH $35.32
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 45.62
  • HTH 60.21
  • Support Level
  • PTGX $49.38
  • HTH $31.19
  • Resistance Level
  • PTGX $51.51
  • HTH $32.16
  • Average True Range (ATR)
  • PTGX 1.97
  • HTH 0.53
  • MACD
  • PTGX -0.81
  • HTH 0.14
  • Stochastic Oscillator
  • PTGX 16.17
  • HTH 72.92

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.

Share on Social Networks: